Pechtner, Valeria
Eli Lilly and Company, Neuilly-Sur-Seine Cedex, France
3 papers on CoChat
Most cited papers
- Verified
Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3)
Umpierrez, G., Tofé Povedano, S., Pérez Manghi, F., Shurzinske, L., & Pechtner, V. (2014) · Diabetes Care
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 341
- Verified
Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: A randomized controlled study
Kabir, M., Skurnik, G., Naour, N., Pechtner, V., Meugnier, E., Rome, S., Quignard-Boulangé, A., Vidal, H., Slama, G., Clément, K., et al. (2007) · The American Journal of Clinical Nutrition
Fatty Acid Research and HealthAdipokines, Inflammation, and Metabolic Diseases
Cited by 316
- Verified
Efficacy and safety of once-weekly dulaglutide versus insulin glargine in patients with type 2 diabetes on metformin and glimepiride (AWARD-2)
Giorgino, F., Benroubi, M., Sun, J.-H., Zimmermann, A. G., & Pechtner, V. (2015) · Diabetes Care
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 268
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free